Cleveland Clinic
Gastroenterology
Dr. Arthur J. McCullough, MD
|
|
Give Review
Arthur McCullough works in the field of Gastroenterology. He went to State University of New York Upstate Medical University. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Arthur McCullough is a published physician. He has 71 papers published. The most current publication "The development of a non-invasive model to predict the presence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease." He is registered with Medicare.
Publications
- Association between high visceral fat area and postoperative complications in patients with Crohn's Disease following primary surgery.
- The development of a non-invasive model to predict the presence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver Disease.
- Clinical Impact of Alcohol-Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United States.
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatoHepatitis: Findings and recommendations from an American Association for the Stud...
- Renin-angiotensin System and fibrosis in non-alcoholic fatty liver disease.
- Age Impacts Ability of Aspartate-Alanine Aminotransferase Ratio to Predict Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
- Response to: laboratory assessment may be dependent on the time of liver biopsy.
- Impact of transjugular intrahepatic portoSystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis.
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatoHepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
- Post-liver transplantation sarcopenia in Cirrhosis: a prospective evaluation.
- Prevalence of celiac disease in Cirrhosis and outcome of Cirrhosis on a gluten free diet: A prospective study.
- The impact of obesity and metabolic syndrome on alcoholic liver Disease.
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
- Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver Disease.
- Management and outcome in hepatorenal Syndrome: need for renal replacement therapy in non-transplanted patients.
- Improved hepatic lipid composition following short-term exercise in nonalcoholic Fatty liver Disease.
- Clinical and histological determinants of nonalcoholic steatoHepatitis and advanced fibrosis in elderly patients.
- An improved measurement of isotopic ratios by high resolution mass spectrometry.
- Reversal of sarcopenia predicts survival after a transjugular intrahepatic portoSystemic stent.
- Editorial: non-alcoholic Fatty liver Disease and obesity: not all about body mass index.
- Risk factors of non-alcoholic fatty liver Disease in patients with inflammatory bowel Disease.
- Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatoHepatitis: a pioglitazone versus vitamin E versus placebo for the trea...
- Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver Disease (NAFLD).
- The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatoHepatitis.
- Role of ceramides in nonalcoholic fatty liver Disease.
- Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need For Colectomy In Patients With Ulcerative Colitis.
- Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease.
- Late evening snack - Exploiting a period of anabolic opportunity in Cirrhosis.
- Alteration in body composition in the portacaval anastamosis rat is mediated by increased expression of myostatin.
- Pentoxifylline improves nonalcoholic steatoHepatitis: A randomized placebo-controlled trial.
- Measuring protein synthesis using metabolic ²H labeling, high-resolution mass spectrometry, and an algorithm.
- Plasma metabolomic profile in nonalcoholic fatty liver Disease.
- Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites.
- Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver Disease.
- Diagnosis and Management of Alcoholic Liver Disease.
- Epidemiology of the Metabolic Syndrome in the United States.
- Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.
- Alcoholic liver Disease.
- Posttransplant metabolic Syndrome: an epidemic waiting to happen.
- Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver Disease.
- Nonalcoholic steatoHepatitis in children: a multicenter clinicopathological study.
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatoHepatitis: a multicenter validation study.
- Glycine and urea kinetics in nonalcoholic steatoHepatitis in human: effect of intralipid infusion.
- Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
- The significance of metabolic Syndrome in the setting of recurrent hepatitis C after liver transplantation.
- Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis.
- Future trends in hepatology: challenges and opportunities.
- Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.
- Noninvasive diagnosis and monitoring of nonalcoholic steatoHepatitis: present and future.
- Differences in regulation of type I collagen synthesis in primary and passaged hepatic stellate cell cultures: the role of alpha5beta1-integrin.
- Altered expression of genes regulating skeletal muscle mass in the portacaval anastomosis rat.
- Pathogenesis of non-alcoholic steatoHepatitis: human data.
- Smoking and increased severity of hepatic fibrosis in primary biliary Cirrhosis: A cross validated retrospective assessment.
- Afternoon colonoscopies have higher failure rates than morning colonoscopies.
- Thiazolidinediones for nonalcoholic steatoHepatitis--promising but not ready for prime time.
- In vivo assessment of liver cell apoptosis as a novel biomarker of Disease severity in nonalcoholic fatty liver Disease.
- Pathophysiology of nonalcoholic steatoHepatitis.
- Improving compliance with postpolypectomy surveillance guidelines: an interventional study using a continuous quality improvement initiative.
- Insulin resistance: a metabolic pathway to chronic liver Disease.
- Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat.
- Obesity and non-alcoholic fatty liver Disease in chronic hepatitis C.
- The clinical features, diagnosis and natural history of nonalcoholic fatty liver Disease.
- Nonalcoholic fatty liver Disease in patients with type 2 diabetes.
- Pathologic features associated with fibrosis in nonalcoholic fatty liver Disease.
- Obesity and its nurturing effect on Hepatitis C.
- Gender differences in the regulation of amino acid metabolism.
- Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat.
- Update on nonalcoholic fatty liver Disease.
- Surprisingly small effect of antiviral treatment in patients with Hepatitis C.
- Diabetes mellitus, obesity, and hepatic steatosis.
Schools
SUNY Upstate Medical University Syracuse
Cleveland Clinic
Mayo Clinic Rochester
Procedures Preformed
- Anoscopy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Mayo School of Graduate Medical Education -
Cleveland Clinic Foundation -
State University of New York Upstate Medical University
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1073570909 | |
| NPPES Provider LastName | MCCULLOUGH | |
| NPPES Provider FirstName | ARTHUR | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 415.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073570909 |
| Last Name Of The Provider | MCCULLOUGH |
| First Name Of The Provider | ARTHUR |
| View All |
Similar Doctors
|
Dr. Anthony B. Post, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Raymond W. Rozman Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Badar Muneer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Acuthan Sourianarayanane, MD |
|
|
Dr. William D. Carey, MD |
|
|
Dr. Jason M. Guardino, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Arumugam Natesan, MB
This Doctor is OpenDoctor Recommended.
|